Tilray Brands (TLRY) Invested Capital (2017 - 2026)
Tilray Brands (TLRY) posted Invested Capital of $44.9 million for Q1 2026, down 0.75% on a QoQ basis from $45.2 million in Q4 2025, and down 2.72% year-over-year from $46.1 million in Q1 2025.
Tilray Brands (TLRY) Invested Capital (2017 - 2026) Analysis & Trends
Tilray Brands' Invested Capital history runs 10 years deep, the most recent figure standing at $44.9 million for Q1 2026.
- Quarterly Invested Capital fell 2.72% year-over-year to $44.9 million in Q1 2026, while the trailing twelve-month figure through Feb 2026 was $181.5 million (down 0.57% YoY) and the FY2025 annual result came in at $45.9 million, up 1.81% from the prior year.
- Invested Capital was $44.9 million for Q1 2026 at Tilray Brands, down from $45.2 million in the prior quarter.
- Across five years, Invested Capital topped out at $77.9 million in Q1 2023 and bottomed at $13.5 million in Q3 2023.
- A 5-year average of $40.5 million and a median of $45.0 million in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital slumped 57.55% — and 2024, when it soared 232.52%.
- Tilray Brands' Invested Capital stood at $26.5 million in 2022, then surged by 116.7% to $57.3 million in 2023, then dropped by 18.87% to $46.5 million in 2024, then declined by 2.79% to $45.2 million in 2025, then decreased by 0.75% to $44.9 million in 2026.
- Business Quant data shows TLRY's Invested Capital at $44.9 million in Q1 2026, $45.2 million in Q4 2025, and $45.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.11 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 31.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.93 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 73.00 Mn |
| 10 | Tilray Brands | 465.02 Mn | 373.06 Mn | 54.95 Mn | 44.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 44.89 Mn |
| Nov 30, 2025 | 45.23 Mn |
| Aug 31, 2025 | 45.55 Mn |
| May 31, 2025 | 45.86 Mn |
| Feb 28, 2025 | 46.14 Mn |
| Nov 30, 2024 | 46.52 Mn |
| Aug 31, 2024 | 44.85 Mn |
| May 31, 2024 | 45.04 Mn |
| Feb 29, 2024 | 57.04 Mn |
| Nov 30, 2023 | 57.35 Mn |
| Aug 31, 2023 | 13.49 Mn |
| May 31, 2023 | 23.38 Mn |
| Feb 28, 2023 | 77.89 Mn |
| Nov 30, 2022 | 26.46 Mn |
| Aug 31, 2022 | 18.28 Mn |
| May 31, 2022 | 18.12 Mn |
| Feb 28, 2022 | 31.59 Mn |
| Nov 30, 2021 | 62.34 Mn |
| Aug 31, 2021 | 30.84 Mn |
| May 31, 2021 | 8.72 Mn |